Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages
Open Access
- 8 September 2023
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 135 (42)
Abstract
Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase‐independent function that can activate pro‐inflammatory gene expression in lipopolysaccharide‐stimulated M1‐like macrophages and cannot be blocked by traditional small‐molecule HDAC3 inhibitors. Here we employed the proteolysis targeting chimera (PROTAC) technology to target the deacetylase‐independent function of HDAC3. We developed a potent and selective HDAC3‐directed PROTAC, P7, which induces nearly complete HDAC3 degradation at low micromolar concentrations in both THP‐1 cells and human primary macrophages. P7 increases the anti‐inflammatory cytokine secretion in THP‐1‐derived M1‐like macrophages. Importantly, P7 decreases the secretion of pro‐inflammatory cytokines in M1‐like macrophages derived from human primary macrophages. This can be explained by the observed inhibition of macrophage polarization from M0‐like into M1‐like macrophage. In conclusion, we demonstrate that the HDAC3‐directed PROTAC P7 has anti‐inflammatory activity and blocks macrophage polarization, demonstrating that this molecular mechanism can be targeted with small molecule therapeutics.Keywords
Funding Information
- China Scholarship Council (202006220019, 201808350110, 201907720019)
- China Scholarship Council (202107060008)
- HORIZON EUROPE Health (101080889)
This publication has 47 references indexed in Scilit:
- Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseasesDrug Discovery Today, 2014
- Enhancement of Inflammatory Protein Expression and Nuclear Factor Κb (NF-Κb) Activity by Trichostatin A (TSA) in OP9 PreadipocytesPLOS ONE, 2013
- Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophagesProceedings of the National Academy of Sciences, 2012
- Histone deacetylase 3 is an epigenomic brake in macrophage alternative activationGenes & Development, 2011
- Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitorsBiochemical Journal, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- The Ubiquitin System for Protein Degradation and Some of Its Roles in the Control of the Cell‐Division Cycle (Nobel Lecture)Angewandte Chemie International Edition, 2005
- Blockade of Histone Deacetylase Inhibitor-Induced RelA/p65 Acetylation and NF-κB Activation Potentiates Apoptosis in Leukemia Cells through a Process Mediated by Oxidative Damage, XIAP Downregulation, and c-Jun N-Terminal Kinase 1 ActivationMolecular and Cellular Biology, 2005
- Histone Deacetylase InhibitorsJournal of Medicinal Chemistry, 2003
- The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene ExpressionMolecular and Cellular Biology, 2001